Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Atkinson

Showing results (31-40 of 373) with videos related to

Pageof 38
Sort By:
European Journal of Immunology|August 13, 2009
The road not taken: a path to curing type 1 diabetes?Michael J Haller, Mark A Atkinson, Desmond A Schatz
Current Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetesMelanie R Shapiro, Mark A Atkinson, Todd M Brusko
Diabetes|October 26, 2011
It's time to mow the GRAS in type 1 diabetesDesmond A Schatz, S Robert Levine, Mark A Atkinson
Cell Stem Cell|December 18, 2014
Stem cells to insulin secreting cells: two steps forward and now a time to pause?Jake A Kushner, Patrick E MacDonald, Mark A Atkinson
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Type I diabetes. PrefaceDesmond A Schatz, Michael J Haller, Mark A Atkinson
Annals of the New York Academy of Sciences|January 6, 2009
The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. PrefaceCarani B Sanjeevi, Desmond A Schatz, Mark A Atkinson
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Efforts to prevent and halt autoimmune beta cell destructionMichael J Haller, Mark A Atkinson, Desmond A Schatz
Lancet (London, England)|July 30, 2013
Type 1 diabetesMark A Atkinson, George S Eisenbarth, Aaron W Michels
The Lancet. Diabetes & Endocrinology|December 24, 2021
The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand stillAaron W Michels, Maria J Redondo, Mark A Atkinson
Attention, Perception & Psychophysics|March 5, 2015
Mental state attribution and the gaze cueing effectGeoff G Cole, Daniel T Smith, Mark A Atkinson
Pageof 38

Showing results (31-40 of 373) with videos related to

Sort By:
Pageof 38
European Journal of Immunology|August 13, 2009
The road not taken: a path to curing type 1 diabetes?Michael J Haller, Mark A Atkinson, Desmond A Schatz
Current Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetesMelanie R Shapiro, Mark A Atkinson, Todd M Brusko
Diabetes|October 26, 2011
It's time to mow the GRAS in type 1 diabetesDesmond A Schatz, S Robert Levine, Mark A Atkinson
Cell Stem Cell|December 18, 2014
Stem cells to insulin secreting cells: two steps forward and now a time to pause?Jake A Kushner, Patrick E MacDonald, Mark A Atkinson
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Type I diabetes. PrefaceDesmond A Schatz, Michael J Haller, Mark A Atkinson
Annals of the New York Academy of Sciences|January 6, 2009
The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. PrefaceCarani B Sanjeevi, Desmond A Schatz, Mark A Atkinson
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Efforts to prevent and halt autoimmune beta cell destructionMichael J Haller, Mark A Atkinson, Desmond A Schatz
Lancet (London, England)|July 30, 2013
Type 1 diabetesMark A Atkinson, George S Eisenbarth, Aaron W Michels
The Lancet. Diabetes & Endocrinology|December 24, 2021
The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand stillAaron W Michels, Maria J Redondo, Mark A Atkinson
Attention, Perception & Psychophysics|March 5, 2015
Mental state attribution and the gaze cueing effectGeoff G Cole, Daniel T Smith, Mark A Atkinson
Pageof 38